Congenital Adrenal Hyperplasia in the Mediterranean: A Concise Overview
Pavlos Fanis, Nicos Skordis, Marios Tomazou, Leonidas A. Phylactou, Vassos Neocleous · 2026
Read Congenital Adrenal Hyperplasia in the Mediterranean: A Concise Overview by Pavlos Fanis, Nicos Skordis, Marios Tomazou, Leonidas A. Phylactou, Vassos Neocleous (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210843.txt.
Description
Pavlos Fanis and co-authors survey congenital adrenal hyperplasia around the Mediterranean in a 2026 review. These inherited disorders block adrenal hormone making, most often through faults in one gene. The team gathers data from twenty-three regions covering over 8.7 million screened newborns. Rates, testing setups, gene patterns, and drug access are compared across countries.
Classic cases arrive in one per ten to twenty-five thousand births where screening is firm, they report. Rates run higher in parts of North Africa and the east basin. Hydrocortisone stays the mainstay drug everywhere. Access to salt balancing and slow release steroids varies widely, and gene factors shape local rates.
Catalog record
| CREATOR | Pavlos Fanis, Nicos Skordis, Marios Tomazou, Leonidas A. Phylactou, Vassos Neocleous |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |